We are live on ! Find out more
APM

Avidity Partners Management Portfolio holdings

AUM $936M
1-Year Est. Return 195%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$3.62B
AUM Growth
+$540M
Cap. Flow
+$569M
Cap. Flow %
15.72%
Top 10 Hldgs %
34.44%
Holding
132
New
36
Increased
34
Reduced
15
Closed
38

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$105M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$93.1M
3
MDT icon
Medtronic
MDT
+$84.8M
4
NUVB icon
Nuvation Bio
NUVB
+$84.1M
5
ABBV icon
AbbVie
ABBV
+$77.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$137M
2
DGX icon
Quest Diagnostics
DGX
+$94.4M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$87.1M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$57.5M
5
ORGO icon
Organogenesis Holdings
ORGO
+$55M

Sector Composition

Rank Sector Weight
1 Healthcare 95.31%
2 Financials 0.29%
3 Industrials 0%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
26
Neurocrine Biosciences
NBIX
$18.2B
$50.7M 1.4%
521,400
+221,400
+74% +$23.2M
BBIO icon
27
BridgeBio Pharma
BBIO
$16.5B
$50.2M 1.39%
+815,100
New +$53.3M
CCXI
28
DELISTED
ChemoCentryx, Inc.
CCXI
$48.2M 1.33%
940,800
+183,800
+24% +$11.1M
XLRN
29
DELISTED
Acceleron Pharma
XLRN
$43.8M 1.21%
322,800
+23,800
+8% +$3.07M
TRIL
30
DELISTED
Trillium Therapeutics Inc.
TRIL
$43.1M 1.19%
4,015,000
+829,800
+26% +$10.3M
ABMD
31
DELISTED
Abiomed Inc
ABMD
$42.2M 1.17%
+132,500
New +$42.4M
NTRA icon
32
Natera
NTRA
$36.4B
$40.2M 1.11%
395,600
-84,200
-18% -$9.23M
STTK icon
33
Shattuck Labs
STTK
$644M
$38.9M 1.07%
1,330,385
+391,572
+42% +$16.5M
INO icon
34
Inovio Pharmaceuticals
INO
$79.6M
$37.2M 1.03%
+333,699
New +$43.9M
KDMN
35
DELISTED
Kadmon Holdings, Inc.
KDMN
$37.1M 1.03%
9,544,200
-25,800
-0.3% -$118K
ATEC icon
36
Alphatec Holdings
ATEC
$1.42B
$36.9M 1.02%
2,334,000
+483,127
+26% +$7.6M
BHVN
37
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$35.8M 0.99%
523,100
+2,000
+0.4% +$162K
IDYA icon
38
IDEAYA Biosciences
IDYA
$3.45B
$34.6M 0.96%
+1,472,000
New +$28.4M
DVAX
39
DELISTED
Dynavax Technologies
DVAX
$34.4M 0.95%
3,500,000
-500,000
-13% -$4.12M
CI icon
40
Cigna
CI
$78.9B
$32.6M 0.9%
+135,000
New +$30.1M
ORTX
41
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$31.3M 0.87%
+431,780
New +$30.7M
LONA
42
LeonaBio Inc
LONA
$67.4M
$30.9M 0.85%
167,785
+63,398
+61% +$14M
ALDX icon
43
Aldeyra Therapeutics
ALDX
$92.3M
$30.3M 0.84%
2,552,000
+1,117,000
+78% +$12.9M
CGEM icon
44
Cullinan Oncology
CGEM
$1.06B
$29.5M 0.81%
+707,359
New +$28.7M
HARP
45
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$29.5M 0.81%
140,800
+62,300
+79% +$12.5M
ACET icon
46
Adicet Bio
ACET
$75.1M
$29.2M 0.81%
+139,375
New +$32M
SHC icon
47
Sotera Health
SHC
$5B
$29M 0.8%
1,161,000
+461,000
+66% +$12.2M
ORGO icon
48
Organogenesis Holdings
ORGO
$332M
$26.7M 0.74%
1,463,403
-4,058,097
-73% -$55M
BLU
49
DELISTED
BELLUS Health Inc.
BLU
$26.1M 0.72%
6,797,400
+1,071,400
+19% +$4.07M
KNSA icon
50
Kiniksa Pharmaceuticals
KNSA
$6.09B
$24.6M 0.68%
1,330,700
+365,400
+38% +$7.47M
1
2
3 4 5

Similar funds

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Avidity Partners Management's Q1 2021 Portfolio in Review

As of Q1 2021, Avidity Partners Management held 132 positions worth $3.62B, up 18% from $3.08B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Avidity Partners Management deployed $569M of net new capital in Q1 2021, opening 36 new positions and adding to 34 existing holdings. Its largest new stake was Intuitive Surgical: 418,200 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 91% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Organogenesis Holdings, an estimated $55M trimmed.

  • Avidity Partners Management's largest Q1 2021 buy was Intuitive Surgical: 418,200 shares worth $103M.
  • Avidity Partners Management added most to Medtronic in Q1 2021, an estimated $84.8M increase.
  • Avidity Partners Management's biggest Q1 2021 reduction was Organogenesis Holdings, cutting an estimated $55M.
  • Avidity Partners Management fully exited Eli Lilly in Q1 2021, selling an estimated $137M.
  • Avidity Partners Management's ten largest holdings make up 34% of its $3.62B portfolio in Q1 2021.
  • Avidity Partners Management opened 36 new positions and closed 38 in Q1 2021.
  • Avidity Partners Management's portfolio value rose 18% quarter-over-quarter to $3.62B.

Based on Avidity Partners Management's 13F filing for Q1 2021, filed 17 May 2021.